Pharma shares fall on new drug policy

Eyeing a presence in the lucrative and growing Russian market, Ahmedabad-based Cadila Pharmaceuticals is looking at investing up to $150 million to build a pharmaceutical manufacturing plant in the Astrakhan Region. Cadila Managing Director Rajiv ...

Pharma major Cadila Healthcare may soon become one of a handful of Indian companies to launch an indigenously developed molecule.

If the recently notified Drugs (Price Control) Order, 2013 spells good news for patients, it certainly causes worry lines for pharma companies, who say their profitability and margins will be affected in the immediate term. As per the order, prices ...

After a phase of low growth (Nov 2012-March 2013), domestic pharmaceutical market has shown some signs of recovery with 9.7% growth for the month of April 2013 versus 5.6% in March 2013. Most stocks under coverage posted growth in-line with market. Amongst ...

India pharma rode on the wave of bunched up patent expiries in the US with many Para IV launches in 2012. In addition, it also benefited from the continuing high teen growth of Indian pharma market. With patent expiries in the US dwindling from $30b ...

Related to : Ranbaxy Laboratories Ltd Ranbaxy Laboratories Ltd BSE 20 May 13 | 03:34 PM 444.15 -27.3 (-5.79%) NSE 20 May 13 | 03:31 PM 443.60 -27.9 (-5.92%) Shares of pharmaceutical companies are under pressure in noon deals trades and declined ...

Mumbai: Indian shares took a breather on Monday and closed marginally in red on profit booking after hitting fresh 2.5 year highs. Pharma companies dragged key equity benchmarks lower while major auto stocks ended in green. The Sensex closed at ...

Drug sales to distributors grew 9.7 per cent (excluding free bonus units) in April this year compared with the previous year. This is higher than the six per cent growth achieved last month, according to data compiled by pharma research firm AIOCD ...

Microbix Biosystems Inc. (Microbix) is a biotechnology company, engaged in the development, manufacturing and distribution of cell-based products and technology. It mainly offers products in the field of virology and cell culture technologies. The ...